This was the stock's fourth consecutive day of losses.

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

This was the stock's second consecutive day of losses.

Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved needle-free epinephrine product, neffy has the potential ...

Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...

Adam Schein discusses why Atlanta Falcons quarterback Matt Ryan needs to be his very best to beat Mitch Trubisky and the Chicago Bears.

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...

The National Association of Wholesaler-Distributors (NAW) announced Henry Schein Chairman and CEO Stanley Bergman will receive its Dirk Van Dongen Lifetime Achievement Award. The Award was named in ...

2025 The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

After hours: February 7 at 4:12:22 PM EST Loading Chart for AMLX ...